OTC’s mission is to accelerate innovative and impactful life science solutions for the patient. To achieve this mission, OTC believes in synergistic collaborations with any entity that shares our “4 Win” Philosophy:

• Win for the Inventor
• Win for the industry/investor
• Win for the institution

And…

• Critical to this, there must be a win for the PATIENT!

OTC Core Values: Discover, Protect, Develop, Execute, Impact

The Office of Technology Commercialization (OTC) is a full-service office dedicated to stimulating innovation and entrepreneurship among faculty, staff and students at the Health Science Center. We provide the following for your innovation; intellectual property protection, strategic partnering agreements to propel research, license negotiation execution surrounding your intellectual property, internal funding to risk mitigate, access to our own accelerator to aid in development, resources and advice to start your own company.

OTC commercialization activities are active in all areas focusing on diabetes, kidney disease, pain (inflammatory and neuropathic with a focus on non-opiod, non-addictive analgesia), cancer (particular expertise in breast/prostrate), aging (and disease), neurodegenerative disorders (Parkinson’s, Alzheimer’s) and regeneration.

Partner early and often, interested entities involved as early as all groups are comfortable.

OTC is committed to providing responsive customer service as well as working collaboratively with external partners who share our mission to positively impact patient outcomes through effective product development.

The University of Texas System Dashboard shows revenue from intellectual property, licenses and options executed, new invention disclosures, startup companies formed and US Patents from UT Health San Antonio, as well as for each UT System academic institution.